165 related articles for article (PubMed ID: 37586457)
21. How to select the best available related or unrelated donor of hematopoietic stem cells?
Tiercy JM
Haematologica; 2016 Jun; 101(6):680-7. PubMed ID: 27252513
[TBL] [Abstract][Full Text] [Related]
22. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
Petersdorf EW; Bengtsson M; De Santis D; Dubois V; Fleischhauer K; Gooley T; Horowitz M; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P; Carrington M; ;
J Clin Oncol; 2020 Aug; 38(24):2712-2718. PubMed ID: 32479188
[TBL] [Abstract][Full Text] [Related]
23. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
Auletta JJ; Kou J; Chen M; Bolon YT; Broglie L; Bupp C; Christianson D; Cusatis RN; Devine SM; Eapen M; Hamadani M; Hengen M; Lee SJ; Moskop A; Page KM; Pasquini MC; Perez WS; Phelan R; Riches ML; Rizzo JD; Saber W; Spellman SR; Stefanski HE; Steinert P; Tuschl E; Yusuf R; Zhang MJ; Shaw BE
Transplant Cell Ther; 2023 Jun; 29(6):346.e1-346.e10. PubMed ID: 36924931
[TBL] [Abstract][Full Text] [Related]
24. HLA-DPB1 matching in unrelated hematopoietic stem cell transplantation program contributes to a higher incidence of disease relapse.
Burek Kamenaric M; Maskalan M; Grubic Z; Mikulic M; Serventi Seiwerth R; Durakovic N; Vrhovac R; Stingl Jankovic K; Zunec R
Hum Immunol; 2017 Nov; 78(11-12):665-671. PubMed ID: 28887054
[TBL] [Abstract][Full Text] [Related]
25. [Probability of high resolution full match for human leukocyte antigen loci in unrelated donors and recipients with low resolution match].
Zhang W; Zhu FM; He YM; Tao SD; Wang W; He JJ; Lü HJ; Yan LX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1617-20. PubMed ID: 21176382
[TBL] [Abstract][Full Text] [Related]
26. [A study of HLA-DPA1 and DPB1 matching status for unrelated donor-recipient pairs matched at allele level for HLA-A, -B, -C, -DRB1 and -DQB1 loci].
Zhen JX; Zou HY; Jin SZ; Gao SQ; Wang DM; He LM; Deng ZH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):697-700. PubMed ID: 24327150
[TBL] [Abstract][Full Text] [Related]
27. Extended HLA Haplotypes and Their Impact on DPB1 Matching of Unrelated Hematologic Stem Cell Transplant Donors.
Linjama T; Räther C; Ritari J; Peräsaari J; Eberhard HP; Korhonen M; Koskela S
Biol Blood Marrow Transplant; 2019 Oct; 25(10):1956-1964. PubMed ID: 31306777
[TBL] [Abstract][Full Text] [Related]
28. Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection.
Greco-Stewart V; Kiernan J; Killeen D; Haun S; Mercer D; Young K; Liwski RS; Allan DS
Transfusion; 2018 Mar; 58(3):718-725. PubMed ID: 29277913
[TBL] [Abstract][Full Text] [Related]
29. Computer program to predict likelihood of finding and HLA-matched donor: methodology, validation, and application.
Mori M; Graves M; Milford EL; Beatty PG
Biol Blood Marrow Transplant; 1996 Oct; 2(3):134-44. PubMed ID: 9199756
[TBL] [Abstract][Full Text] [Related]
30. A study of selected hematopoietic stem cell donors provided by an intermediate size registry.
Nicoloso G; Kürsteiner O; Bussmann F; Marbacher M; Tiercy JM
Eur J Haematol; 2019 Oct; 103(4):426-432. PubMed ID: 31385372
[TBL] [Abstract][Full Text] [Related]
31. Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation.
Buhler S; Baldomero H; Ferrari-Lacraz S; Mamez AC; Masouridi-Levrat S; Heim D; Halter J; Nair G; Chalandon Y; Schanz U; Güngör T; Nicoloso G; Passweg JR; Villard J;
Blood Adv; 2021 Sep; 5(17):3377-3386. PubMed ID: 34448833
[TBL] [Abstract][Full Text] [Related]
32. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
33. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.
Passweg JR; Schanz U; Chalandon Y; Güngör T; Baldomero H; Heim D; Nair G; Medinger M; Masouridi-Levrat S; de Faveri GN; Tiercy JM;
Bone Marrow Transplant; 2015 Sep; 50(9):1201-5. PubMed ID: 26052916
[TBL] [Abstract][Full Text] [Related]
34. Estimation of optimal donor number in Bone Marrow Donor Registry: Hong Kong's experience.
Kwok J; Guo M; Yang W; Ip P; Chan GCF; Ho J; Lee CK; Middleton D; Lu L
Hum Immunol; 2017 Oct; 78(10):610-613. PubMed ID: 28865670
[TBL] [Abstract][Full Text] [Related]
35. Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.
Dubois V; Detrait M; Sobh M; Morisset S; Labussière H; Giannoli C; Nicolini F; Moskovtchenko P; Mialou V; Ducastelle S; Rey S; Thomas X; Barraco F; Tedone N; Marry E; Garnier F; Bertrand Y; Michallet M
Hum Immunol; 2016 Nov; 77(11):1008-1015. PubMed ID: 26902994
[TBL] [Abstract][Full Text] [Related]
36. High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry.
Buck K; Wadsworth K; Setterholm M; Maiers M; Confer D; Hartzman R; Schmidt A; Yang SY; Dehn J
Biol Blood Marrow Transplant; 2016 Apr; 22(4):759-763. PubMed ID: 26724431
[TBL] [Abstract][Full Text] [Related]
37. Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10/10, 9/10-HLA matched donors and cord blood.
Granier C; Biard L; Masson E; Porcher R; Peffault de Latour R; Robin M; Boissel N; Xhaard A; Ribaud P; Lengline E; Larghero J; Charron D; Loiseau P; Socié G; Dhédin N
Am J Hematol; 2015 Oct; 90(10):897-903. PubMed ID: 26149659
[TBL] [Abstract][Full Text] [Related]
38. Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.
Rappazzo KC; Zahurak M; Bettinotti M; Ali SA; Ambinder AJ; Bolaños-Meade J; Borrello I; Dezern AE; Gladstone D; Gocke C; Fuchs E; Huff CA; Imus PH; Jain T; Luznik L; Rahmat L; Swinnen LJ; Wagner-Johnston N; Jones RJ; Ambinder RF
Transplant Cell Ther; 2021 Nov; 27(11):909.e1-909.e6. PubMed ID: 34425261
[TBL] [Abstract][Full Text] [Related]
39. HLA-Matched Unrelated Donors for Patients with Sickle Cell Disease: Results of International Donor Searches.
Tozatto-Maio K; Torres MA; Degaide NHS; Cardoso JF; Volt F; Pinto ACS; Oliveira D; Elayoubi H; Kashima S; Loiseau P; Veelken H; Ferster A; Cappelli B; Rodrigues ES; Scigliuolo GM; Kenzey C; Ruggeri A; Rocha V; Simões BP; Tamouza R; Gluckman E
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2034-2039. PubMed ID: 32712327
[TBL] [Abstract][Full Text] [Related]
40. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
Kindwall-Keller TL; Ballen KK
Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
